These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15095314)

  • 1. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma.
    Li AA; Ng E; Shi W; Lee A; Chia M; Liu TJ; Huang D; O'Sullivan B; Gullane P; Liu FF
    Int J Cancer; 2004 Jun; 110(3):452-8. PubMed ID: 15095314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma.
    Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF
    Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.
    Chia MC; Shi W; Li JH; Sanchez O; Strathdee CA; Huang D; Busson P; Klamut HJ; Liu FF
    Mol Ther; 2004 Jun; 9(6):804-17. PubMed ID: 15194047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
    Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
    Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.
    Hui AB; Yue S; Shi W; Alajez NM; Ito E; Green SR; Frame S; O'Sullivan B; Liu FF
    Clin Cancer Res; 2009 Jun; 15(11):3716-24. PubMed ID: 19470731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
    Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
    Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
    Mäkitie AA; MacMillan C; Ho J; Shi W; Lee A; O'Sullivan B; Payne D; Pintilie M; Cummings B; Waldron J; Warde P; Irish J; Brown D; Gilbert R; Gullane P; Liu FF; Kamel-Reid S
    Clin Cancer Res; 2003 Jun; 9(6):2177-84. PubMed ID: 12796384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer.
    Calbó J; Marotta M; Cascalló M; Roig JM; Gelpí JL; Fueyo J; Mazo A
    Cancer Gene Ther; 2001 Oct; 8(10):740-50. PubMed ID: 11687897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells].
    Bai X; Che F; Li J; Ma Y; Zhou Y; Zhai J; Meng L
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):354-8. PubMed ID: 11866935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
    Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.
    Li JH; Lax SA; Kim J; Klamut H; Liu FF
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential utility of BimS as a novel apoptotic therapeutic molecule.
    Yip KW; Li A; Li JH; Shi W; Chia MC; Rashid SA; Mocanu JD; Louie AV; Sanchez O; Huang D; Busson P; Yeh WC; Gilbert R; O'sullivan B; Gullane P; Liu FF
    Mol Ther; 2004 Sep; 10(3):533-44. PubMed ID: 15336653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells.
    Zhong J; Min L; Huang H; Li L; Li D; Li J; Ma Z; Dai L
    Technol Cancer Res Treat; 2013 Jun; 12(3):269-74. PubMed ID: 23289480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of targeted FasL in nasopharyngeal carcinoma.
    Li JH; Shi W; Chia M; Sanchez-Sweatman O; Siatskas C; Huang D; Busson P; Klamut H; Yeh WC; Richardson C; O'Sullivan B; Gullane P; Neligan P; Medin J; Liu FF
    Mol Ther; 2003 Dec; 8(6):964-73. PubMed ID: 14664799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
    Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
    Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral p16/CDKN2 gene transfer to malignant glioma: role of p16 in growth, invasion, and senescence.
    Kim SK; Wang KC; Cho BK; Lim SY; Kim YY; Oh CW; Chung YN; Kim CY; Lee CT; Kim HJ
    Oncol Rep; 2003; 10(5):1121-6. PubMed ID: 12883667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.